Radiologex Unveils R-DEE Protocol Network and Announces Limited RDGX Token Pre-Sale
Disclaimer: The text below is a press release that is not part of Cryptonews.com editorial content.
Radiologex Technologies Ltd. proudly presents the debut of the R-DEE Protocol™ Network by Radiologex, a bespoke blockchain solution for the global healthcare IT sector. After more than five years of relentless research, development, rigorous testing, and comprehensive validation, Radiologex is on the brink of transforming healthcare IT with its market-ready R-DEE Protocol Network and the accompanying R-DEE suite—a robust, next-generation health IT productivity software suite tailored for the global healthcare industry.
In tandem with this landmark launch, Radiologex Technologies Ltd. is set to initiate the eagerly anticipated distribution of RDGX tokens. The exclusive Pre-Sale event will present a highly limited offering of just 2.5 million tokens, underscoring the exclusivity and the significant demand forecasted for this consequential digital asset.
Radiologex has self-bootstrapped the development of the R-DEE Protocol Network, empowering token purchasers to invest in a product that is both complete and operational. This approach is a testament to Radiologex’s commitment to delivering a fully realized, enterprise-grade solution, bolstering buyer confidence.
The R-DEE Protocol Network brings forth a game-changing economic incentive for Node Validators. With a cap of 12,500 Node Validator licenses, the program offers an unmatched opportunity to engage with a network renowned for its advanced technology and limited availability, ensuring distinct significance for each Validator. A commitment of 10,000 RDGX tokens secures a Node Validator License, which is essential for authenticating healthcare Digital IDs and audit trails—key
Read more on cryptonews.com
